| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |